Institute of Biochemistry of Biologically Active Compounds offers consumers a diagnostic test system for the detection of antigens of the SARS-CoV-2 virus and influenza A and B viruses by immunochromatographic analysis under a manufacturing agreement and is looking for partners interested in a distribution services agreement.

Diagnostic test system for the detection of antigens of the SARS-CoV-2 virus and influenza A and B viruses by immunochromatographic analysis (registration certificate of the Ministry of Health of the Republic of Belarus IM-7.113467.

The test system is designed to detect the antigen of the SARS-CoV-2 virus and influenza A and B viruses and is based on a method using immunochromatography for the qualitative determination of the SARS-CoV-2 antigen (N-antigen) and influenza A viruses (H1N1/H3N2) and "B" (B/Victoria, B/Yamagata).

Test systems are used in clinical laboratory diagnostics in healthcare institutions and research organizations, as well as for self-control.

The Institute's Product Catalog for the development and production of diagnostic kits, reagents and solutions for laboratory research, auxiliary laboratory reagents and accessories can be found here (in Russian).

Innovative products of the Institute.

In the structural subdivisions of the institute, research is carried out in the field of vitaminology, the study of molecular mechanisms of regulation of metabolism in normal and pathological conditions, the biochemistry of alcohol and drug addiction, neurochemistry and pharmacology.

The main activities are as follows: conducting fundamental and applied research aimed at studying the mechanisms of pathogenesis of diseases of the liver, cardiovascular and endocrine systems, alcohol dependence, pathological conditions associated with a deficiency of essential micronutrients and the effects of stress, in order to develop methods for their prevention, diagnosis and therapy; development of new innovative medicines, vitamin preparations, dietary supplements, as well as the development of methods for the isolation and purification of biologically active compounds from herbal medicinal raw materials, the development of their laboratory production for the needs of the pharmaceutical industry.

The Institute has developed unique technologies for obtaining dry extracts from medicinal plant materials and spicy-aromatic plants for use as components:
- in the production of dietary supplements,
- in the food industry,
- in the production of perfumery.

It is possible to manufacture under the order products of deep processing and purification of extracts from plant materials for use as analytical standards.

The Institute of Biochemistry of Biologically Active Compounds of the National Academy of Sciences of Belarus specializes in the development and production of diagnostic reagent kits for biochemical, hematological studies, reagent kits for the diagnosis of malignant neoplasms, infectious diseases, and the study of thyroid and reproductive functions.

Designed and manufactured kits allow you to get consistently reproducible and accurate results at an affordable price. Company strategy aimed at innovative development. Reagent kits are used on semi-automatic and automatic laboratory systems, as well as in manual testing. Adaptations for automatic analyzers can be provided optionally.

The Institute of Biochemistry of Biologically Active Compounds of the National Academy of Sciences of Belarus represents in the Republic of Belarus the world's leading manufacturers of reagents and materials, as well as products of its own production under the trademark "Institute of Biochemistry of Biologically Active Compounds of the National Academy of Sciences of Belarus".
The mission of the Institute is to meet the needs of scientists in high-quality reagents for scientific research at the best prices in order to save budget funds.

Consumers interested in purchasing diagnostic test systems for the detection of antigens of the SARS-CoV-2 virus and influenza A and B viruses by immunochromatographic analysis under a manufacturing agreement.

Partners interested in purchasing diagnostic test systems for the detection of antigens of the SARS-CoV-2 virus and influenza A and B viruses by immunochromatographic analysis under a distribution services agreement.